We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Agilent Introduces Dried Blood-Spotting Sample-Prep Card that Outperforms Cellulose-Based Cards
Product News

Agilent Introduces Dried Blood-Spotting Sample-Prep Card that Outperforms Cellulose-Based Cards

Agilent Introduces Dried Blood-Spotting Sample-Prep Card that Outperforms Cellulose-Based Cards
Product News

Agilent Introduces Dried Blood-Spotting Sample-Prep Card that Outperforms Cellulose-Based Cards


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Agilent Introduces Dried Blood-Spotting Sample-Prep Card that Outperforms Cellulose-Based Cards"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Agilent Technologies Inc. has introduced the Bond Elut DMS (Dried Matrix Spotting) sample-preparation card for dried blood-spotting bioanalysis. The proprietary design delivers a number of advantages over conventional cellulose-based cards.

Dried blood-spotting analysis is an emerging technique in biological research. It allows researchers to substantially reduce costs and time-consuming steps compared to liquid sample-prep procedures, while maintaining analytical accuracy.

Main applications include drug metabolism and pharmacokinetics studies.

The non-cellulose Bond Elut DMS is not impregnated with reagents. This reduces non-specific binding of analytes, increasing mass-spectrometry response and improving the signal-to-noise ratio.

The new Agilent product is compatible with standard punching tools and automation, and requires five times less punching force compared to cellulose-based cards. This results in faster workflow, less technician fatigue and smoother automation.

Bond Elut DMS also delivers consistent spot shape, size and reproducibility, regardless of ratio of red blood cells to blood sample volume.

Agilent collaborated with five global pharmaceutical and contract research organizations to develop Bond Elut DMS for the pharmaceutical bioanalysis market.

“No other company offers a more complete suite of sample-preparation techniques for bioanalysis than Agilent,” said Paul Boguszewski, Agilent product manager, Sample Preparation Products.

Boguszewski continued, “We provide solid phase extraction, protein precipitation/filtration, supported liquid extraction and dried blood-spotting consumables. They’re perfect complements to our well-known families of LC columns and systems, and broad portfolio of high-sensitivity mass spectrometry instrumentation.”

Advertisement